Oncoshot

Delighted to partner with Amazon Web Services (AWS) and participate in its annual Public Sector Day at Raffles City Convention Centre yesterday. Was great to share Oncoshot's work with Federated Data systems and our experiences in tackling the challenges of data extraction, restructuring and secure models of insights sharing in Oncology. Noorbakht Khan, Solutions Architect, was also on stage to go into the details of the AWS solutions that have helped Oncoshot build a trusted, secure and scalable federated data architecture. Thank you to the audience for interest in our oncology LLM. There's much work being done in this space to implement our Oncology LLMs locally for healthcare system partners in the region. Please feel to reach out to us if you'd like to better understand how AI/LLM can support data-driven clinical trials and RWE capabilities or other use cases. Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson Shabbir Syed Abdul Thanuja Naidu David Chia Aik Shin GOH Rajesh SUKUMARAN Joey K.

Oncoshot was delighted to attend the inaugural MSK iHub Challenge over the last few days. A big thank you and congrats to Jae Zhong Svetlana (Lana) Voskoboynik, MPH and Rick Peng on the launch of the #DCT challenge.

Oncoshot team was delighted to present our work on "Harnessing Federated Databases for Transformative Clinical and Genomic Data Management," at the recent AWS Genomics Community Day in Singapore. Our presentation focused on the potential of clinical and genomic data in cancer clinical trials. We shared our experience and success across APAC in creating the foundations for data-driven clinical trials workflows. We were also honored to receive the Go-To-Market Award at the event. As we aim to increase our adoption amongst healthcare system partners globally, we are excited to work with the AWS team. More details about our solutions and capabilities can be accessed via the AWS marketplace. #Genomics #ClinicalTrials #Healthcare #AWS

Opportunities within the Singapore clinical research ecosystem. #Singapore #clinicalresearch

Here's my take on Roche's planned sale of Flatiron Health. The work and early success of Flatiron around 2015-2018 greatly inspired my thinking about the unique challenges of the APAC ecosystem and whether a different model was needed to make data sharing a reality in healthcare systems outside of the US. The growth and challenges of Flatiron and other data companies in the US have been instructive in defining Oncoshot's role as a model for cancer data management and data sharing in APAC. Here's my take on the divestiture, the learnings for Oncoshot and why we're confident about the future of healthcare data sharing in the space of #clinicaltrials and #RWE. Oncoshot Oncoshot India Ruslan Enikeev Chee Yong Chua Dr. Nilesh Atre Andrew Wilson Tam C. Nguyen Shabbir Syed Abdul Hon. Jaala Pulford Anvesh Ramineni Cheryl Teo Deborah Yeo Zubin Daruwalla Deepraj Singh Sawhney David Toh Simon Hopkins Bernard Ng

Discover how the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group, led by Protocol Chair Professor Pierce Chow, is tackling the HCC epidemic in the region. With over 25 years of pioneering research, 62 participating centres, and 4,000+ patients enrolled in groundbreaking studies, AHCC is making strides in early diagnosis, innovative treatments, and collaborative efforts to improve patient outcomes. Learn more about their key achievements, ongoing trials, and commitment to advancing HCC care in our latest article. Together, we're driving progress against liver cancer and fostering a spirit of regional cooperation. Read the full article here: https://lnkd.in/gZBJTPA9

Delighted to be at American Society of Clinical Oncology (ASCO)'s #ASCO2024 in Chicago since Wednesday with Head of Sales, David Chia. It's been fantastic meeting with our industry partners and collaborators and running into medical oncology colleagues at the convention centre :) AI and the issues around maximising its potential in cancer research and clinical care continue to take centre stage across the event. In yesterday's opening session, Microsoft's Jonathan M Carlson reiterated that the challenges in AI and Clinical trial was not the technology - it is all about the #ecosystem. Taking some liberty in paraphrasing, Jonathan, " Successful implementation of AI is dependent on resolving questions of where is the data, how do we use it ethically and what are the business models that are needed to make it work." Am glad that we at Oncoshot have invested our efforts in building this ecosystem across APAC and now the UK. Grateful as well for the partners who see the importance in enabling and investing into these ecosystems. Looking forward to meeting up with the rest of our partners over the next 2 days here!

Our CEO shared about Oncoshot’s work across the region in supporting realtime and secure insights sharing to power clinical trials country and site selection, feasibility and recruitment as well as the role of #federated data in RWE. Great to see the interest amongst leading industry professional from Pharma and CRO at the event to learn about the unique innovations in Singapore.

Patient-centricity in clinical research #Patient-centricity is a keyword or buzzword many of us hear about in conferences. In the Asia-Pacific region which patient-centric solutions have been present in patient facing solutions for clinical care, we're at the beginnings of truly embedding patient-centricity when it comes to clinical research. Involving patients in the early stages of clinical research ensures that research priorities align with patient needs, ultimately leading to the development of more relevant and impactful interventions. Post-marketing, patient engagement facilitates the collection of real-world evidence, providing insights into treatment effectiveness and safety in diverse patient populations. Within clinical development, patient input aids in the design of more patient-friendly trials, leading to improved recruitment and retention. Market authorization and reimbursement processes benefit from patient involvement as well, ensuring that approved treatments address unmet patient needs and are accessible to those who can benefit from them. Embracing a patient-centric approach at each stage not only enhances the relevance and effectiveness of healthcare interventions but also fosters a sense of inclusivity and empowerment among patients. But is this all there is to patient-centricity in clinical research and can we do more? At @Oncoshot, we're very excited about new models of patient-centricity that can be enabled with data. If you're a healthcare system and would like to explore our futuristic work with #preconsent solutions for clinical trials and research, do reach out to us. #patient-centricity #clinicalresearch #cancer #clinicaltrials #patient #preconsent

Thank you for all our attendees, speakers, and panelists for attending Fortrea APAC Real World Evidence Hybrid-Webinar Event on 24th April! We had physical event at our Singapore office and real time virtual webinar connecting attendees, speakers, and panelists from various Asia Pacific countries, including Australia, China, India, Japan, Singapore, South Korea, and others. It was great to get together to discuss the challenges of Real-World Evidence (RWE) studies, how the development of Digital Health and Innovations has transformed RWE studies in APAC, and what else can be done to overcome the unaddressed gaps! At Fortrea, we lead with science! #RWE #Fortrea Joanna Lim Susana Coruña Kah Leng Leong Pramod Gawli Huren Sivaraj Andrew Makmur